High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progressionNuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphomaSushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertaseValidation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancerHigh MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanomaNuclear T-STAR protein expression correlates with HER2 status, hormone receptor negativity and prolonged recurrence free survival in primary breast cancer and decreased cancer cell growth in vitro.Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancerUp-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarrayExpression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patientsAssociations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability.Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study.Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort studyComprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanomaHigh expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer.PKCalpha expression is a marker for breast cancer aggressiveness.High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype.Translational database selection and multiplexed sequence capture for up front filtering of reliable breast cancer biomarker candidates.Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival.Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancerHomeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro.CD99 is a novel prognostic stromal marker in non-small cell lung cancer.Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration.Multiple miscarriages are associated with the risk of ovarian cancer: results from the European Prospective Investigation into Cancer and NutritionmiR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro.Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patientsDown-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features.Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer.Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancerMolecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study.Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosisPrognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in miceCyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression.SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma
P50
Q21203667-E9DFC14B-A3C9-463F-87A0-289A3C30CE1CQ24297520-5774086D-B2BD-4048-93B5-60468A2E486CQ24328755-C78567B6-17DA-461E-A9C7-A4EFB492AC4BQ27496689-913D8FC7-149F-4BBA-B25C-EEF06E4E2A5CQ27498879-E8A8613F-2880-442C-B908-A8B67DF9A217Q30009589-907E2457-64D1-4135-A137-A33EA816D05FQ31034941-C82BC055-4B89-4279-8424-7F2EC57686EDQ33548538-54DCC7BF-1603-4995-9155-AD30190921D2Q33606254-3CF91E01-D324-4891-964C-D4729FB97CEFQ33613989-5C5EE91B-434D-435A-990E-FC27C883FDE6Q33694866-96F4637E-FF67-4888-B095-B586D695C1B4Q33696650-79E01F79-AA9E-4146-B414-2834986F9F2BQ33726716-C69A9B09-E44B-426F-A3B4-8D98F6BE4B38Q33740175-B97D44F9-DB10-4DC4-B99F-A013523F97CBQ33758934-3B627EDC-5411-4CA9-A7A4-BB727BD3212BQ33762715-A72C70C1-5A9D-458A-962D-846ECDDFBE2FQ33794854-C7BC63CB-1348-46EB-81B6-14FB3FB73704Q33798605-BC00D3FF-49BB-43BB-9CF7-12CB4F6F251EQ33864132-2CC43736-F92A-46DA-8645-7AD7D856C163Q33867326-25BF5096-6C77-4C18-8D61-1AC01445688EQ33869036-DF342D76-C214-4C41-80AA-00696133AACAQ33941129-1A34F9DB-1578-4DCF-A557-04FA780D79D2Q33986711-A5085E91-8249-4A53-82D5-56141EF624E4Q34116879-0384F88C-CFF2-4724-B6C7-CF575FCECD8FQ34173527-88D8DD94-1029-4B6B-BDEF-958955A57D62Q34258877-230DC151-3305-49AC-8BD1-20E8CB652E8BQ34259934-7D22C504-7966-4A7E-B009-712CA44EB8E5Q34279823-F278BFE0-540C-451C-949D-37E5FD400B60Q34305636-ACB56DD2-96EF-4E70-A388-F626C57D68B8Q34333522-61A5B0B3-29A9-4E9D-9C85-654AA22D4ACEQ34348172-4EF74B42-9A44-4C6E-9E71-163A55F2F8A1Q34358413-3BD30AA5-0D9A-4A86-87C7-234CF7F33EFCQ34429766-B9335B37-67E5-4EB4-B12C-14C880291B97Q34485296-1048A365-AF72-4E7E-B23C-D98EBF2D0789Q34493998-09570D6D-FA1A-4A3F-8C9B-38464D6E7C29Q34514322-04623F8B-BB16-4AF8-8359-0C0AB8297CFBQ34515112-6975ED8F-6CF9-4BB0-B6C0-91848CF36B0BQ34519881-FBE57196-6125-4D16-840E-795C0BE590FCQ34555832-5FF0F306-EB12-4B0C-ADAB-53AB40D17763Q34577656-17D8D97B-2DA5-4473-B4EA-B75EA4A1A2FE
P50
name
Karin Jirström
@ast
Karin Jirström
@en
Karin Jirström
@es
Karin Jirström
@ga
Karin Jirström
@nl
Karin Jirström
@sl
Karin Jirström
@sq
Karin Jirström
@sv
type
label
Karin Jirström
@ast
Karin Jirström
@en
Karin Jirström
@es
Karin Jirström
@ga
Karin Jirström
@nl
Karin Jirström
@sl
Karin Jirström
@sq
Karin Jirström
@sv
prefLabel
Karin Jirström
@ast
Karin Jirström
@en
Karin Jirström
@es
Karin Jirström
@ga
Karin Jirström
@nl
Karin Jirström
@sl
Karin Jirström
@sq
Karin Jirström
@sv
P108
P1960
KrA2pN0AAAAJ
P21
P27
P31
P569
1965-01-01T00:00:00Z